Original Research
Published on 29 Nov 2021
Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
in T Cell Biology
- 6,069 views
- 9 citations